Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
NCT05687435
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
240
Enrollment
OTHER
Sponsor class
Conditions
Diarrhea-Predominant Irritable Bowel Syndrome
Interventions
DRUG:
Changyanning tablet
OTHER:
Changyanning tablet placebo
Sponsor
Mei Han